SCHEMBL1108039

SCHEMBL1108039

CCCCCC[n+]1ccc(-c2cc[n+](CCCCCC)cc2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 1.00
MEN1 O00255 3/20 1.00
MAPT P10636 2/20 1.00
TP53 P04637 1/20 1.00
CYP1A2 P05177 1/20 1.00
CYP2D6 P10635 1/20 1.00
CYP2C9 P11712 1/20 1.00
CYP2C19 P33261 1/20 1.00
HTT P42858 4/20 0.95
SMN1; SMN2 Q16637 3/20 0.95
LMNA P02545 2/20 0.95
KDM4E B2RXH2 1/20 0.95
NPC1 O15118 1/20 0.95
RAB9A P51151 1/20 0.95
CHRM2 P08172 2/20 0.64
ADRA2A P08913 2/20 0.64
ADORA3 P0DMS8 2/20 0.64
CHRM1 P11229 2/20 0.64
ACHE P22303 2/20 0.64
SLC6A2 P23975 2/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3204377 1.00 KMT2A (1.00) KMT2AMEN1MAPTTP53CYP1A2
SCHEMBL3221223 1.00 KMT2A (1.00) KMT2AMEN1MAPTTP53CYP1A2
SCHEMBL1305855 1.00 KMT2A (1.00) KMT2AMEN1MAPTTP53CYP1A2
SCHEMBL3212489 1.00 KMT2A (1.00) KMT2AMEN1MAPTTP53CYP1A2
SCHEMBL3215753 1.00 KMT2A (1.00) KMT2AMEN1MAPTTP53CYP1A2
SCHEMBL3205110 1.00 KMT2A (1.00) KMT2AMEN1MAPTTP53CYP1A2
SCHEMBL3212749 1.00 KMT2A (1.00) KMT2AMEN1MAPTTP53CYP1A2
SCHEMBL3215320 1.00 KMT2A (1.00) KMT2AMEN1MAPTTP53CYP1A2
SCHEMBL3196438 1.00 KMT2A (1.00) KMT2AMEN1MAPTTP53CYP1A2
SCHEMBL3196317 1.00 KMT2A (1.00) KMT2AMEN1MAPTTP53CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 312 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119020012-A Electrochromic material with visible light and near infrared light transmittance respectively adjustable, preparation method thereof and electrochromic device 宁波华瓴光学技术有限公司 2024-11-26 CN claimed
CN-114276795-A Environment-friendly electrochromic gel, electrochromic device and preparation method thereof 深圳市华科创智技术有限公司 2022-04-05 CN claimed
CN-114262459-A Color-changeable plastic 现代自动车株式会社 2022-04-01 CN claimed
US-20260146277-A1 APPLICATION FOR PEPTIDE NUCLEIC ACID (PNA) BLOCKER BECTON, DICKINSON AND COMPANY (US) 2026-05-28 US disclosed
US-20260139306-A1 USING RANDOM PRIMING TO OBTAIN FULL-LENGTH V(D)J INFORMATION FOR IMMUNE REPERTOIRE SEQUENCING BECTON DICKINSON AND CO (US) 2026-05-21 US disclosed
EP-4745247-A2 SELECTIVE EXTENSION IN SINGLE CELL WHOLE TRANSCRIPTOME ANALYSIS Becton, Dickinson and Company (US) 2026-05-20 EP disclosed
US-12630874-B1 Using random priming to obtain full-length V(D)J information for immune repertoire sequencing BECTON, DICKINSON AND COMPANY (US) 2026-05-19 US disclosed
WO-2026059707-A9 METHODS FOR CONJUGATING SEQUENCES OF INTEREST TO BEADS IN A SINGLE BULK REACTION BECTON, DICKINSON AND COMPANY (US) 2026-05-15 WO disclosed
US-20260132399-A1 BEAD-BASED SINGLE CELL SECRETOME ANALYSIS BECTON DICKINSON AND CO (US) 2026-05-14 US disclosed
US-20260125740-A1 PRIMERS FOR IMMUNE REPERTOIRE PROFILING BECTON DICKINSON CO (US) 2026-05-07 US disclosed
US-12606859-B2 Cell capture using DU-containing oligonucleotides BECTON, DICKINSON AND COMPANY (US) 2026-04-21 US disclosed
US-20100132772-A1 METHOD FOR MANUFACTURING NANO-ARRAY ELECTRODE AND PHOTOELECTRIC CONVERSION DEVICE USING SAME NIPPON OIL CORPORATION (JP) 2010-06-03 US disclosed
US-20100041916-A1 PROCESS FOR PRODUCTION OF SULFONIC ACID ESTER WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2010-02-18 US disclosed
US-7658864-B2 Liquid crystal composition, optical compensation film and liquid crystal display device FUJIFILM CORPORATION (JP) 2010-02-09 US disclosed
US-20090273740-A1 OPTICAL COMPENSATORY FILM, POLARIZING PLATE, AND LIQUID CRYSTAL DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2009-11-05 US disclosed
EP-2067770-A1 PROCESS FOR PRODUCTION OF SULFONIC ACID ESTER Wako Pure Chemical Industries, Ltd. (JP) 2009-06-10 EP disclosed
US-20090009693-A1 Liquid Crystal Composition, Optical Compensation Film and Liquid Crystal Display Device FUJIFILM CORPORATION (JP) 2009-01-08 US disclosed
US-20080202578-A1 Photocharge Separation Using Supramolecular Complex of Ii-Electron Type Extended Viologen Derivative And Porphyrin JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2008-08-28 US disclosed
US-7348125-B2 Optical information recording medium and novel immonium compound FUJIFILM CORPORATION (JP) 2008-03-25 US disclosed
US-7311950-B2 Composition, optical compensatory film and liquid crystal display FUJIFILM CORPORATION (JP) 2007-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100041916-A1 PROCESS FOR PRODUCTION OF SULFONIC ACID ESTER SULT1A1, SULT2A1, STS KMT2A 3198/4885MEN1 3623/4885MAPT 4771/4885
US-20260132399-A1 BEAD-BASED SINGLE CELL SECRETOME ANALYSIS SCTR, SPPL2B, IGFBP1 KMT2A 4392/4885MEN1 1390/4885MAPT 4186/4885
US-20080202578-A1 Photocharge Separation Using Supramolecular Complex of Ii-Electron Type Extended Viologen Derivative And Porphyrin PPOX, PPIG, CRY2 KMT2A 1876/4885MEN1 4349/4885MAPT 2437/4885
US-20260146277-A1 APPLICATION FOR PEPTIDE NUCLEIC ACID (PNA) BLOCKER RNGTT, POLI, TARBP1 KMT2A 2423/4885MEN1 3902/4885MAPT 2611/4885
US-12630874-B1 Using random priming to obtain full-length V(D)J information for immune repertoire sequencing POLL, POLK, MICA KMT2A 2963/4885MEN1 4049/4885MAPT 4169/4885
US-20260139306-A1 USING RANDOM PRIMING TO OBTAIN FULL-LENGTH V(D)J INFORMATION FOR IMMUNE REPERTOIRE SEQUENCING POLL, POLK, MICA KMT2A 2623/4885MEN1 3859/4885MAPT 4220/4885
US-20260125740-A1 PRIMERS FOR IMMUNE REPERTOIRE PROFILING CD74, BCR, MYD88 KMT2A 4046/4885MEN1 4586/4885MAPT 3599/4885
US-12606859-B2 Cell capture using DU-containing oligonucleotides CPSF6, CPSF1, NUDT21 KMT2A 1910/4885MEN1 3014/4885MAPT 2014/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.